Clinical Trial Update: Concurrent WOKVAC Vaccination, Chemotherapy, and HER2-Targeted Monoclonal Antibody Therapy Before Surgery for the Treatment of Patients With Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating concurrent WOKVAC vaccination, chemotherapy, and HER2-targeted monoclonal antibody therapy before surgery in breast cancer pat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Chemotherapy (chemotherapy)
• HER2-targeted monoclonal antibody therapy
• WOKVAC vaccine (WOKVAC vaccine)

Snippet

Sponsor: University of Washington | Conditions: Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8 | Phase 2 | Status: RECRUITING